These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1641167)

  • 1. Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.
    Vera-Ramirez M; Charlet M; Parry GJ
    Neurology; 1992 Aug; 42(8):1636-7. PubMed ID: 1641167
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term treatment of chronic relapsing inflammatory demyelinating polyradiculoneuropathy: combination of corticosteroids, plasma exchange, and intravenous immunoglobulins.
    Briellmann RS; Nydegger UE; Sturzenegger M; Fierz L; Hess CW; Hauser SP
    Eur Neurol; 1998; 39(3):190-1. PubMed ID: 9605400
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy and in neuropathy associated with IgM monoclonal gammopathy of unknown significance.
    Dyck PJ
    Neurology; 1990 Feb; 40(2):327-8. PubMed ID: 2300259
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of recurrent aseptic meningitis caused by high-dose intravenous gammaglobulin therapy for chronic inflammatory demyelinating polyneuropathy].
    Kato T; Suzuki E; Sone M; Yoshida E; Hirayama M
    Rinsho Shinkeigaku; 2001 Nov; 41(11):797-800. PubMed ID: 12080612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningitis and skin reaction after intravenous immune globulin therapy.
    Catteau B; Delaporte E; Piette F
    Ann Intern Med; 1997 Dec; 127(12):1130. PubMed ID: 9412321
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-D immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy.
    Vermeulen M; van Schaik IN; Brand A
    J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):383-4. PubMed ID: 7897433
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic demyelinating polyneuropathy in pregnancy treated with intravenous immunoglobulin.
    Nwosu EC; Tandon S; Breeze C; Enevoldson TP; Khaleeli AA
    Br J Obstet Gynaecol; 1999 Feb; 106(2):174-6. PubMed ID: 10426685
    [No Abstract]   [Full Text] [Related]  

  • 8. The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy.
    Brand A; Van Doorn PA; Rossi F; Kazatchkine MD; Vermeulen M
    Prog Clin Biol Res; 1990; 337():405-9. PubMed ID: 2353004
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
    Thompson N; Choudhary P; Hughes RA; Quinlivan RM
    J Neurol; 1996 Mar; 243(3):280-5. PubMed ID: 8936360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
    Nobile-Orazio E; Bersano A
    Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose intravenous immune globulin and acute renal failure.
    Ellie E; Combe C; Ferrer X
    N Engl J Med; 1992 Oct; 327(14):1032-3. PubMed ID: 1518546
    [No Abstract]   [Full Text] [Related]  

  • 12. Aseptic meningitis associated with high dose intravenous immunoglobulin therapy.
    Casteels-Van Daele M; Wijndaele L; Brock P; Kruger M; Gillis P
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):980-1. PubMed ID: 1431974
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin.
    Choudhary PP; Hughes RA
    QJM; 1995 Jul; 88(7):493-502. PubMed ID: 7633875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aseptic meningitis and intravenous immunoglobulin therapy.
    Harati Y; Shaibani AI
    Ann Intern Med; 1995 Feb; 122(4):316. PubMed ID: 7825774
    [No Abstract]   [Full Text] [Related]  

  • 15. Aseptic meningitis and intravenous immunoglobulin therapy.
    Peetermans WE; Van Wijngaerden E; Knockaert DC
    Ann Intern Med; 1995 Feb; 122(4):316; author reply 316-7. PubMed ID: 7825775
    [No Abstract]   [Full Text] [Related]  

  • 16. Aseptic meningitis and intravenous immunoglobulin therapy.
    Scribner CL; Kapit RM; Phillips ET; Rickles NM
    Ann Intern Med; 1994 Aug; 121(4):305-6. PubMed ID: 8037414
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.
    van Doorn PA; Brand A; Strengers PF; Meulstee J; Vermeulen M
    Neurology; 1990 Feb; 40(2):209-12. PubMed ID: 2405291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous gammaglobulin for chronic inflammatory demyelinating polyneuropathy.
    Currò Dossi B; Tezzon F
    Ital J Neurol Sci; 1987 Aug; 8(4):321-6. PubMed ID: 3119516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aseptic meningitis as complication of intravenous immunoglobulin therapy for myasthenia gravis.
    Meiner Z; Ben-Hur T; River Y; Reches A
    J Neurol Neurosurg Psychiatry; 1993 Jul; 56(7):830-1. PubMed ID: 8380010
    [No Abstract]   [Full Text] [Related]  

  • 20. Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis.
    Ellis RJ; Swendson MR; Bajorek J
    Muscle Nerve; 1994 Jun; 17(6):683-4. PubMed ID: 8196714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.